| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $306.0M | — | +229.6% |
| Cost of Revenue | $47.4M | — | +122.9% |
| R&D Expense | $209.5M | — | +37.3% |
| SG&A Expense | $247.3M | — | +67.6% |
| Operating Income | -$153.3M | — | +38.2% |
| Pre-tax Income | -$162.1M | — | +36.6% |
| Income Tax | $1.5M | — | +60.6% |
| Net Income | -$163.6M | — | +36.3% |
| EPS (Basic) | -$0.76 | — | +46.5% |
| EPS (Diluted) | -$0.76 | — | +46.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $582.2M | +14.1% | +44.4% |
| Short-term Investments | $641.3M | -30.3% | -19.5% |
| Accounts Receivable | $178.6M | +26.8% | +274.0% |
| Inventory | $132.9M | +0.6% | +32.0% |
| Current Assets | $1.61B | -10.1% | +15.0% |
| Total Assets | $2.08B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$222.7M | — | +15.0% |
| Capital Expenditures | $3.5M | — | -65.4% |
| Investing Cash Flow | $265.5M | — | +230.2% |
| Financing Cash Flow | $29.5M | — | +1.8% |
| Free Cash Flow | -$226.2M | — | +16.9% |
| +15.2% |
| Current Liabilities | $361.0M | -23.0% | +50.9% |
| Long-term Debt | $546.8M | +0.0% | -51.3% |
| Total Liabilities | $1.37B | -10.1% | -19.5% |
| Stockholders' Equity | $704.9M | -4.6% | +610.8% |